Wall Street Analysts Think Terns Pharmaceuticals (TERN) Could Surge 78.74%: Read This Before Placing a Bet

Shares of Terns Pharmaceuticals, Inc. (TERN) have gained 3.7% over the past four weeks to close the last trading session at $7.95, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14.21 indicates a potential upside of 78.7%. The average comprises seven short-term price targets ranging from a low of $5.50 to a high of $22, with a standard deviation of $5.92. While the lowest esti ...